Biomarker Discovery Outsourcing Services Market Size, Trends, Analysis, and Outlook By Type (Predictive biomarkers, Prognostic biomarkers, Safety biomarkers, Surrogate endpoints), By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases, Others), By Discovery Phase (Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development, Biomarker Selection), By End-User (Pharmaceutical Companies, Biotechnology Companies, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Biomarker Discovery Outsourcing Services market size is poised to register 21.53% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biomarker Discovery Outsourcing Services market across By Type (Predictive biomarkers, Prognostic biomarkers, Safety biomarkers, Surrogate endpoints), By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases, Others), By Discovery Phase (Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development, Biomarker Selection), By End-User (Pharmaceutical Companies, Biotechnology Companies, Others).
The Biomarker Discovery Outsourcing Services Market is experiencing notable growth and innovation driven by the increasing demand for biomarker research services, omics technologies, and bioinformatics expertise to identify and validate novel biomarkers for disease diagnosis, prognosis, and therapeutic monitoring in biomedical research, clinical diagnostics, and drug development applications. Biomarkers are measurable indicators of biological processes, disease states, or pharmacological responses that provide insights into disease mechanisms, treatment efficacy, and patient outcomes, enabling researchers and healthcare providers to make informed diagnostic and therapeutic decisions based on molecular signatures and personalized patient profiles. Key trends include the adoption of high-throughput omics platforms, multiplexed biomarker assays, and machine learning algorithms to analyze complex biological data, discover disease-specific biomarkers, and prioritize biomarker candidates for clinical validation and translation. Additionally, there is a growing emphasis on collaborative biomarker discovery consortia, biobanking initiatives, and data sharing platforms to facilitate collaborative research, accelerate biomarker discovery workflows, and promote transparency and reproducibility in biomarker research efforts. Moreover, collaborative partnerships between biomarker research companies, academic research institutions, and pharmaceutical companies are essential for advancing biomarker discovery projects, validating biomarker panels, and translating biomarker findings into clinical applications, enabling the development of precision diagnostics and targeted therapies for improved patient care and disease management across diverse medical specialties and therapeutic areas.
Biomarker Discovery Outsourcing Services Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biomarker Discovery Outsourcing Services market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biomarker Discovery Outsourcing Services survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biomarker Discovery Outsourcing Services industry.
Key market trends defining the global Biomarker Discovery Outsourcing Services demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biomarker Discovery Outsourcing Services Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Biomarker Discovery Outsourcing Services industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biomarker Discovery Outsourcing Services companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biomarker Discovery Outsourcing Services industry
Leading Biomarker Discovery Outsourcing Services companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biomarker Discovery Outsourcing Services companies.
Biomarker Discovery Outsourcing Services Market Study- Strategic Analysis Review
The Biomarker Discovery Outsourcing Services market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Biomarker Discovery Outsourcing Services industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Biomarker Discovery Outsourcing Services Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Biomarker Discovery Outsourcing Services Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Biomarker Discovery Outsourcing Services market segments. Similarly, Strong end-user demand is encouraging Canadian Biomarker Discovery Outsourcing Services companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Biomarker Discovery Outsourcing Services market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biomarker Discovery Outsourcing Services Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biomarker Discovery Outsourcing Services industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Biomarker Discovery Outsourcing Services market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biomarker Discovery Outsourcing Services Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biomarker Discovery Outsourcing Services in Asia Pacific. In particular, China, India, and South East Asian Biomarker Discovery Outsourcing Services markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Biomarker Discovery Outsourcing Services Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biomarker Discovery Outsourcing Services Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biomarker Discovery Outsourcing Services market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biomarker Discovery Outsourcing Services.
Biomarker Discovery Outsourcing Services Market Company Profiles
The global Biomarker Discovery Outsourcing Services market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Celerion, Charles River Laboratories., Eurofins Scientific, Evotec, GHO Capital, ICON plc, Laboratory Corp of America Holdings, Parexel International (MA) Corp, Proteome Sciences, Thermo Fisher Scientific Inc
Recent Biomarker Discovery Outsourcing Services Market Developments
The global Biomarker Discovery Outsourcing Services market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biomarker Discovery Outsourcing Services Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Predictive biomarkers
Prognostic biomarkers
Safety biomarkers
Surrogate endpoints
By Therapeutic Area
Oncology
Neurology
Cardiology
Autoimmune Diseases
Others
By Discovery Phase
Biomarker Identification
Biomarker Validation
Biomarker Profiling
Biomarker Panel Development
Biomarker Selection
By End-user
Pharmaceutical Companies
Biotechnology Companies
Others
Geographical Segmentation:
Celerion
Charles River Laboratories.
Eurofins Scientific
Evotec
GHO Capital
ICON plc
Laboratory Corp of America Holdings
Parexel International (MA) Corp
Proteome Sciences
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The Biomarker Discovery Outsourcing Services Market is experiencing notable growth and innovation driven by the increasing demand for biomarker research services, omics technologies, and bioinformatics expertise to identify and validate novel biomarkers for disease diagnosis, prognosis, and therapeutic monitoring in biomedical research, clinical diagnostics, and drug development applications. Biomarkers are measurable indicators of biological processes, disease states, or pharmacological responses that provide insights into disease mechanisms, treatment efficacy, and patient outcomes, enabling researchers and healthcare providers to make informed diagnostic and therapeutic decisions based on molecular signatures and personalized patient profiles. Key trends include the adoption of high-throughput omics platforms, multiplexed biomarker assays, and machine learning algorithms to analyze complex biological data, discover disease-specific biomarkers, and prioritize biomarker candidates for clinical validation and translation. Additionally, there is a growing emphasis on collaborative biomarker discovery consortia, biobanking initiatives, and data sharing platforms to facilitate collaborative research, accelerate biomarker discovery workflows, and promote transparency and reproducibility in biomarker research efforts. Moreover, collaborative partnerships between biomarker research companies, academic research institutions, and pharmaceutical companies are essential for advancing biomarker discovery projects, validating biomarker panels, and translating biomarker findings into clinical applications, enabling the development of precision diagnostics and targeted therapies for improved patient care and disease management across diverse medical specialties and therapeutic areas.
Biomarker Discovery Outsourcing Services Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biomarker Discovery Outsourcing Services market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biomarker Discovery Outsourcing Services survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biomarker Discovery Outsourcing Services industry.
Key market trends defining the global Biomarker Discovery Outsourcing Services demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biomarker Discovery Outsourcing Services Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Biomarker Discovery Outsourcing Services industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biomarker Discovery Outsourcing Services companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biomarker Discovery Outsourcing Services industry
Leading Biomarker Discovery Outsourcing Services companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biomarker Discovery Outsourcing Services companies.
Biomarker Discovery Outsourcing Services Market Study- Strategic Analysis Review
The Biomarker Discovery Outsourcing Services market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Biomarker Discovery Outsourcing Services industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Biomarker Discovery Outsourcing Services Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Biomarker Discovery Outsourcing Services Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Biomarker Discovery Outsourcing Services market segments. Similarly, Strong end-user demand is encouraging Canadian Biomarker Discovery Outsourcing Services companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Biomarker Discovery Outsourcing Services market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biomarker Discovery Outsourcing Services Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biomarker Discovery Outsourcing Services industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Biomarker Discovery Outsourcing Services market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biomarker Discovery Outsourcing Services Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biomarker Discovery Outsourcing Services in Asia Pacific. In particular, China, India, and South East Asian Biomarker Discovery Outsourcing Services markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Biomarker Discovery Outsourcing Services Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biomarker Discovery Outsourcing Services Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biomarker Discovery Outsourcing Services market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biomarker Discovery Outsourcing Services.
Biomarker Discovery Outsourcing Services Market Company Profiles
The global Biomarker Discovery Outsourcing Services market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Celerion, Charles River Laboratories., Eurofins Scientific, Evotec, GHO Capital, ICON plc, Laboratory Corp of America Holdings, Parexel International (MA) Corp, Proteome Sciences, Thermo Fisher Scientific Inc
Recent Biomarker Discovery Outsourcing Services Market Developments
The global Biomarker Discovery Outsourcing Services market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biomarker Discovery Outsourcing Services Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Predictive biomarkers
Prognostic biomarkers
Safety biomarkers
Surrogate endpoints
By Therapeutic Area
Oncology
Neurology
Cardiology
Autoimmune Diseases
Others
By Discovery Phase
Biomarker Identification
Biomarker Validation
Biomarker Profiling
Biomarker Panel Development
Biomarker Selection
By End-user
Pharmaceutical Companies
Biotechnology Companies
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Celerion
Charles River Laboratories.
Eurofins Scientific
Evotec
GHO Capital
ICON plc
Laboratory Corp of America Holdings
Parexel International (MA) Corp
Proteome Sciences
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Biomarker Discovery Outsourcing Services Market Overview and Key Findings, 2024
1.2 Biomarker Discovery Outsourcing Services Market Size and Growth Outlook, 2021- 2030
1.3 Biomarker Discovery Outsourcing Services Market Growth Opportunities to 2030
1.4 Key Biomarker Discovery Outsourcing Services Market Trends and Challenges
1.4.1 Biomarker Discovery Outsourcing Services Market Drivers and Trends
1.4.2 Biomarker Discovery Outsourcing Services Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biomarker Discovery Outsourcing Services Companies
2. BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET SIZE OUTLOOK TO 2030
2.1 Biomarker Discovery Outsourcing Services Market Size Outlook, USD Million, 2021- 2030
2.2 Biomarker Discovery Outsourcing Services Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Predictive biomarkers
Prognostic biomarkers
Safety biomarkers
Surrogate endpoints
By Therapeutic Area
Oncology
Neurology
Cardiology
Autoimmune Diseases
Others
By Discovery Phase
Biomarker Identification
Biomarker Validation
Biomarker Profiling
Biomarker Panel Development
Biomarker Selection
By End-user
Pharmaceutical Companies
Biotechnology Companies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biomarker Discovery Outsourcing Services Market, 2025
5.2 Asia Pacific Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biomarker Discovery Outsourcing Services Market, 2025
5.5 Europe Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.6 Europe Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biomarker Discovery Outsourcing Services Market, 2025
5.8 North America Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.9 North America Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biomarker Discovery Outsourcing Services Market, 2025
5.11 South America Pacific Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.12 South America Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biomarker Discovery Outsourcing Services Market, 2025
5.14 Middle East Africa Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biomarker Discovery Outsourcing Services Market Size Outlook and Revenue Growth Forecasts
6.2 US Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
7. BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOMARKER DISCOVERY OUTSOURCING SERVICES COMPANY PROFILES
8.1 Profiles of Leading Biomarker Discovery Outsourcing Services Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Celerion
Charles River Laboratories.
Eurofins Scientific
Evotec
GHO Capital
ICON plc
Laboratory Corp of America Holdings
Parexel International (MA) Corp
Proteome Sciences
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Biomarker Discovery Outsourcing Services Market Overview and Key Findings, 2024
1.2 Biomarker Discovery Outsourcing Services Market Size and Growth Outlook, 2021- 2030
1.3 Biomarker Discovery Outsourcing Services Market Growth Opportunities to 2030
1.4 Key Biomarker Discovery Outsourcing Services Market Trends and Challenges
1.4.1 Biomarker Discovery Outsourcing Services Market Drivers and Trends
1.4.2 Biomarker Discovery Outsourcing Services Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biomarker Discovery Outsourcing Services Companies
2. BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET SIZE OUTLOOK TO 2030
2.1 Biomarker Discovery Outsourcing Services Market Size Outlook, USD Million, 2021- 2030
2.2 Biomarker Discovery Outsourcing Services Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Predictive biomarkers
Prognostic biomarkers
Safety biomarkers
Surrogate endpoints
By Therapeutic Area
Oncology
Neurology
Cardiology
Autoimmune Diseases
Others
By Discovery Phase
Biomarker Identification
Biomarker Validation
Biomarker Profiling
Biomarker Panel Development
Biomarker Selection
By End-user
Pharmaceutical Companies
Biotechnology Companies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biomarker Discovery Outsourcing Services Market, 2025
5.2 Asia Pacific Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biomarker Discovery Outsourcing Services Market, 2025
5.5 Europe Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.6 Europe Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biomarker Discovery Outsourcing Services Market, 2025
5.8 North America Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.9 North America Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biomarker Discovery Outsourcing Services Market, 2025
5.11 South America Pacific Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.12 South America Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biomarker Discovery Outsourcing Services Market, 2025
5.14 Middle East Africa Biomarker Discovery Outsourcing Services Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biomarker Discovery Outsourcing Services Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biomarker Discovery Outsourcing Services Market Size Outlook and Revenue Growth Forecasts
6.2 US Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biomarker Discovery Outsourcing Services Industry Drivers and Opportunities
7. BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOMARKER DISCOVERY OUTSOURCING SERVICES COMPANY PROFILES
8.1 Profiles of Leading Biomarker Discovery Outsourcing Services Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Celerion
Charles River Laboratories.
Eurofins Scientific
Evotec
GHO Capital
ICON plc
Laboratory Corp of America Holdings
Parexel International (MA) Corp
Proteome Sciences
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
